Some Immunohistochemical Features of Argyrophilic Grain Dementia With Normal Cortical Choline Acetyltransferase Levels but Extensive Subcortical Pathology and Markedly Reduced Dopamine
Restricted accessResearch articleFirst published online January, 1992
Some Immunohistochemical Features of Argyrophilic Grain Dementia With Normal Cortical Choline Acetyltransferase Levels but Extensive Subcortical Pathology and Markedly Reduced Dopamine
Detailed immunohistochemical and biochemical studies are reported on two cases of progressive dementia showing no Alzheimer-type pathology but extensive argyrophilic grains as described previously by Braak and Braak. These cases had no specific clinical features, and the pathology of these brains showed subcortical gliosis (proliferation of astrocytes and microglia) without significant neuronal losses. Interesting novel immunohistochemical findings were the profuse appearance of complement-activated oligodendrocytes and oligodendroglial microtubular masses. Their appearance seems to indicate oligodendroglial reactions to widespread damage of myelinated axons. Cortical levels of choline acteyltransferase were normal, but striatal levels of dopamine and its metabolites were markedly reduced. This disease may be consistent with the criteria for progressive subcortical gliosis. (J Geriatr Psychiatry Neurol 1992;5:3–13).
Get full access to this article
View all access options for this article.
References
1.
1. Braak H, Braak E: Cortical and subcortical argyrophilic grains characterize a disease associated with adult onset dementia. Neuropathol Appl Neurobiol1989; 15:13–26.
2.
2. Braak H, Braak E: Argyrophilic grains: Characteristic pathology of cerebral cortex in cases of adult onset dementia without Alzheimer changes. Neurosci Lett1987; 76:124–127.
3.
3. Itagaki S. McGeer PL, Akiyama H, et al: A case of adult-onset dementia with argyrophilic grains. Ann Neurol1989; 26:685–689.
4.
4. Masliah E, Hansen LA, Quijada S, et al: Late onset dementia with argyrophilic grains and subcortical tangles or atypical progressive supranuclear palsy?Ann Neurol1991; 29:389–396.
5.
5. Khachaturian ZS: Diagnosis of Alzheimer's disease. Arch Neurol1985; 42:1097–1105.
6.
6. McGeer EG, McGeer PL, Akiyama H, et al: Cortical glutaminase, β-glucuronidase and glucose utilization in Alzheimer's disease. Can J Neurol Sci1989; 16:511–515.
7.
7. Cross AJ, Crow TJ, Dawson JM, et al: Subcellular pathology of human neurodegenerative disorders: Alzheimer-type dementia and Huntington's disease. J Neurochem1986; 47:882–889.
8.
8. Lowry OH, Rosebrough NJ, Farr AL, et al: Protein measurement with the Folin phenol reagent. J Biol Chem1951; 193:265–275.
9.
9. O'Kusky JR, Boyes BE, McGeer EG: Methylmercury-induced movement and postural disorders in developing rat: Regional analysis of brain catecholamines and indoleamines. Brain Res1988; 439:138–146.
10.
10. Damsma G, Boisvert DP, Mudrick L, et al: Effects of transient forebrain ischemia and pargyline on extracellular concentrations of dopamine, serotonin, and their metabolites in the rat striatum as determined by in vivo microdialysis. J Neurochem1990; 54:801–808.
11.
11. Yamada T, McGeer PL: Oligodendroglial microtubular masses: An abnormality observed in some human neurodegenerative diseases. Neurosci Lett1990; 120:163–166.
12.
12. McGeer PL, Itagaki S, Tago H, et al: Reactive microglia in patients with senile dementia of the Alzheimer type are positve for the histocompatibility protein HLA-DR. Neurosci Lett1987; 9:195–200.
13.
13. McGeer PL, Itagaki S, McGeer EG: Expression of the histocompatibility glycoprotein HLA-DR in neurological disease. Acta Neuropathol1988; 76:550–557.
14.
14. Yamada T, Akiyama H, McGeer PL: Complement-activated oligodendroglia: A new pathogenic entity identified by immunostaining with antibodies to human complement proteins C3d and C4d. Neurosci Lett1990; 112:161–166.
15.
15. Knopman DS, Mastri AR, Frey WH II, et al: Dementia lacking distinctive histologic features. Neurology1990; 40:251–256.
16.
16. Neuman MA, Cohn R: Progressive subcortical gliosis, a rare form of presenile dementia. Brain1967; 90:405–418.
17.
17. Verity MA, Roitberg B, Kepes JJ: Mesolimbo-cortical dementia: Clinicopathological studies on two cases. J Neurol Neurosurg Psychiatry1990; 53:492–495.
18.
18. Brun A: Frontal lobe degeneration of non-Alzheimer type I. Neuropathology. Arch Gerontol Geriatr1987; 6:193–208.
19.
19. Minagawa M, Nakazato T: A special form of presenile dementia. Psychiatr Neurol Jpn1973; 75:79–93.
20.
20. Masse G, Mikol J, Brion S: Atypical presenile dementia: Report of an anatomo-clinical case and review of the literature. J Neurol Sci1981; 52:245–267.
21.
21. Will RG, Lees AJ, Gibb W, et al: A case of progressive subcortical gliosis presenting clinically as Steele-Richardson-Olszewski syndrome. J Neurol Neurosurg Psychiatry1988; 51:1224–1227.
22.
22. Moossy J, Martinez AJ, Hanin I, et al: Thalamic and subcortical gliosis with dementia. Arch Neurol1987; 44:510–513.
23.
23. Khoubesserian P, Davous P, Bianco C, et al: Déemence familiale de type Neumann (gliose sous corticale). Rev Neurol (Paris)1985; 141:706–712.
24.
24. Delacourte A: General and dramatic glial reaction in Alzheimer brain. Neurology1990; 40:33–37.
25.
25. Falment S, Delacourte A: Tau marker??Nature1990; 346:22.
26.
26. Yamaguchi H, Nakazato Y, Shoji M, et al: Ultrastructure of the neuropil threads in the Alzheimer brain: Their dendritic origin and accumulation in the senile plaques. Acta Neuropathol1990; 80:368–374.
27.
27. Papp MI, Kahn JE, Lantos PL: Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci1989; 94:79–100.
28.
28. Horoupian DS: Cytoplasmic oligodendroglial inclusions in a patient with striatonigral degeneration, olivopontocerebellar atrophy and “atypical” Pick's disease, abstract. Neurobiol Aging1990; 11:272.
29.
29. Nakazato Y, Yamazaki H, Hirato J, et al: Oligodendroglial microtubular tangles in olivopontocerebellar atrophy. J Neuropathol Exp Neurol1990; 49:521–530.
30.
30. Mackenzie IC, Bickenbach JR, et al: Reactivity of epidermal Langerhaus cells to a histochemical marker for demonstration of β-glucuronidase. J Invest Dermatol1982; 78:239–242.
31.
31. Riekkinen PJ, Soininen H, Sirvio J, et al: Dementia without cholinergic deficit. Gerontology1987; 33:268–272.
